Document is current
Any future updates will be listed below
-
Authors
Oridate, Nobuhiko
Smedby, Thea
Ruzza, Chiara
Roth, Michaela
Mehta, Mansi
Akachi, Yoko
Skovgaard, Rasmus
Itagaki, Takatoshi
-
Funding
Funding for this research was provided by:
Atos Medical, part of Coloplast A/B
- License Information
-
More Information
Article History
Received: 14 May 2025
Accepted: 23 September 2025
First Online: 14 October 2025
Declarations
:
: Not applicable, this study does not involve human or animal participants. Published data was used to develop the model.
: Not applicable.
: TS, TI, CR, RS and MR are employed by Atos Medical/Coloplast, a manufacturer of HMEs such as Provox Life. NO is a Professor at Yokohama City University Graduate School of Medicine, and received compensation from Atos Medical for the contribution to the model validation and this manuscript.MM and YA are employees of IQVIA, who were commissioned by Atos Medical/Coloplast to provide project management and consultancy, develop the Japan cost-effectiveness model adaptation, and draft the manuscript. MM and YA are employees of IQVIA, who were commissioned by Atos Medical/Coloplast to provide project management and consultancy, develop the Japan cost-effectiveness model adaptation, and draft the manuscript.
